ペプチドと脂質ペプチドの超分子共ポリマーとその治療的可能性
Ruomeng Qiu1, Ivan R Sasselli1,2, Zaida Álvarez2,3
1Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States.
Journal of the American Chemical Society
|March 17, 2022
まとめ
研究者は自己組織化ペプチドを用いた 新種の超分子共ポリマーを開発しました これらのペプチドバイオマテリアルは,制御された薬物投与の可能性を示し,アルツハイマー病のモデルにおける神経細胞の生存能力を高めています.
科学分野:
- 超分子化学
- ペプチドの自己組み立て
- バイオマテリアル科学
背景:
- 超分子ペプチド化学により,高度な生体材料が作られます.
- ペプチドは 治療薬として 有望な候補です
- ペプチドの組成を制御することは 機能的な材料を設計する上で 鍵となるものです
研究 の 目的:
- 脂質と溶解性のペプチドの共組を調査する.
- 調節可能な内部構造を持つ 超分子コポリマーを作る
- これらのコポリマーの薬剤投与および治療応用の可能性を調査する.
主な方法:
- 脂質ベータシート形成ペプチドと溶解ペプチドの共組
- 異なる濃度での超分子共ポリマー構造の特徴化.
- ペプチド放出メカニズムと熱力学的転移安定性の評価
- アルツハイマー病の薬剤候補を用いたコポリマー機能のインビトロ試験
主要な成果:
- コアセンブリにより,内部の順序が異なる超分子コポリマーが得られる.
- 低濃度では,溶解性ペプチドは水中のコンパートメントで保護された.
- 高濃度では,コポリメリゼーションによりベータシートの二次構造が破壊された.
- 熱力学的転移性により,自発的なペプチド単体放出が促進された.
結論:
- 超分子共ポリマーは バイオマテリアルデザインの 汎用性のあるプラットフォームを提供します
- これらのアセンブリからのペプチドの制御された放出は,有効な薬物投与メカニズムを示しています.
- これらのシステムは,アルツハイマー病の文脈で神経細胞の活性を向上させました.
関連する概念動画
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.6K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
2.4K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.4K
01:21Drugs for Treatment of Constipation-Predominant IBS
1.5K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.5K
01:26Peptic Ulcer Disease IV: Management
815
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
815
01:29Chronic Pancreatitis II: Collaborative Care
572
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
572
01:21Chronic Pancreatitis II: Pathophysiology
35
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
35